Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Apply
CLN-978
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step